Nerve block injection for postural tachycardia syndrome compared with a saline sham injection
Tests a stellate ganglion block against a sham injection in adults with postural tachycardia syndrome.
Key facts
- Who runs it
- Stanford University
- Where
- Stanford, United StatesSee the 2 sites
- Trial code
- Registry title
- Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome
- Status
- Recruiting
- People taking part
- 20 people, planned
- Started
- 16 Oct 2025
- Expected to end
- May 2027
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Stellate ganglion block
- Sham injection of saline
- Ropivacaine
- Normal saline
- Record updated
- 28 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults diagnosed with POTS (Postural Tachycardia Syndrome, a fast heartbeat on standing up). It tests a nerve block in the neck against a fake (sham) injection.
- Age
- >18 years
- Sex
- All sexes can join.
- Disease stage
- A diagnosis of POTS.
Main reasons for not taking part
- Allergy to local anesthetics (numbing drugs).
- Severe problems with blood clotting.
- Past or current significant heart rhythm problems, heart failure or myocarditis (heart inflammation).
- Pulmonary embolism (lung blood clot) needing blood thinners, pulmonary fibrosis or other lung problems that may cause POTS symptoms.
- Not able to keep medicines stable during the study.
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Adult patients (>18 years of age) diagnosed with POTS
- Ability to provide informed consent
- Ability to comply with 3 follow up visits
- English speaking and capable of signing informed consent and complying with protocol requirements
Who cannot take part
- Inability to maintain a stable medication regiment for the duration of the study
- Allergy to local anesthetics
- History of or currently being treated for clinically significant ongoing cardiac arrhythmia, heart failure, myocarditis, pulmonary embolism requiring anticoagulation, pulmonary fibrosis or other pulmonary diagnosis that in the investigator's opinion may contribute to symptoms of POTS
- Severe coagulopathy
Where in United States
- Stanford UniversityStanford, United StatesContact: Anna Maria Bombardieri, MDTaking people
- Stanford University School of MedicineStanford, United StatesContact: Anna Maria Bombardieri, MD, PhDTaking people
About the trial
What the trial wants to find out
This single-center study aims to evaluate both immediate and long-term outcomes of stellate ganglion block (SGB) in a cohort of rigorously phenotyped patients with Postural Tachycardia Syndrome (POTS). By assessing the effects of SGB, this study seeks to determine its viability as an intervention for symptom control in POTS.
The 2 groups in the trial
- Intervention Group (stellate ganglion block)Treatment being tested
Patients will receive an ultrasound guided stellate ganglion block (SGB) with 10 ml of 0.5% ropivacaine.
Treatment: Stellate ganglion block and Ropivacaine
- Control Group (sham injection with saline)Sham treatment, for comparison
Patients will receive a subcutaneous sham injection with saline. Ultrasound imaging will be used to simulate the guidance process as in the active procedure, maintaining consistency in the procedural experience.
Treatment: Sham injection of saline and Normal saline
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome: A Randomized Double Blind Sham Placebo-controlled Pilot Study
- Plain-language title
- Nerve block injection for postural tachycardia syndrome compared with a saline sham injectionGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 28 October 2026